Protriptyline HCl (vivactil HCl).
D000818:Animals; D000928:Antidepressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D001007:Anxiety / Q000139:chemically induced; D001259:Ataxia / Q000139:chemically induced; D001714:Bipolar Disorder / Q000188:drug therapy*; D003072:Cognition Disorders / Q000139:chemically induced; D003248:Constipation / Q000139:chemically induced; D003863:Depression / Q000188:drug therapy* / Q000628:therapy; D003986:Dibenzocycloheptenes / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology / Q000600:supply & distribution / Q000627:therapeutic use*; D004285:Dogs; D004344:Drug Incompatibility; D004357:Drug Synergism; D004422:Dystonia Musculorum Deformans / Q000139:chemically induced; D004565:Electroconvulsive Therapy; D005221:Fatigue / Q000139:chemically induced; D005260:Female; D005901:Glaucoma; D006261:Headache / Q000139:chemically induced; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D008199:Lymphadenitis / Q000139:chemically induced; D051379:Mice; D008996:Monoamine Oxidase Inhibitors; D009325:Nausea / Q000139:chemically induced; D010276:Parasympatholytics / Q000627:therapeutic use; D011247:Pregnancy; D011437:Propylamines / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology / Q000600:supply & distribution / Q000627:therapeutic use*; D011680:Pupil / Q000187:drug effects; D011707:Pyloric Stenosis; D011817:Rabbits; D051381:Rats; D013566:Sympathomimetics; D013610:Tachycardia / Q000139:chemically induced; D014202:Tremor / Q000139:chemically induced; D014555:Urination Disorders; D014786:Vision Disorders / Q000139:chemically induced
D000928:Antidepressive Agents; D003986:Dibenzocycloheptenes; D008996:Monoamine Oxidase Inhibitors; D010276:Parasympatholytics; D011437:Propylamines; D013566:Sympathomimetics